Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded
- Contract number
- SPE2DB25FSZ83
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,488
Award facts
- Contract value 100% obligated
- $18,488.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $18,488.12 by the Defense Logistics Agency on September 15, 2025, for Trikafta 100-50-75 mg/150 mg tablets (84-count units). The contract carries no set-aside designation and has an ultimate completion date of September 16, 2025, with performance occurring at the vendor's Park Ridge, Illinois location. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026.
Trikafta is a prescription medication used to treat cystic fibrosis, and this delivery order represents a routine pharmaceutical supply fulfillment to support Department of Defense healthcare facilities. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure multiple delivery orders across the DLA's extensive IDC vehicle. The company's portfolio demonstrates consistent capability in distributing branded prescription drugs, biologics, and medical consumables to military health facilities nationwide, positioning it as a reliable partner for specialized pharmaceutical procurement needs.
Quick answers
Who was awarded contract SPE2DB25FSZ83?
SPE2DB25FSZ83 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FSZ83 worth?
The government has obligated $18,488 on SPE2DB25FSZ83.
Is contract SPE2DB25FSZ83 an order under another contract?
Yes. SPE2DB25FSZ83 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FSZ83 competed?
The extent of competition for SPE2DB25FSZ83 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award